Peptic Ulcer Drugs Market Increasing Demand With Leading Players Daewoong Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Pfizer Inc., Cadila Healthcare Ltd, Novitium Pharma LLC, Yuhan Corporation

Global Peptic Ulcer Drugs Market to Grow Rapidly due to Increasing Applications in Healthcare

Growing prevalence of peptic ulcers, increased acceptance of peptic ulcer drugs over surgery, R&D stimulation through government policies, increased number of generic producers for peptic ulcer, improvements in disease management, etc., are factors driving the growth of the global peptic ulcer drug market.
In addition, variables such as the rising prevalence of stress-induced ulcers due to changing lifestyle and diet, increasing smoking rate, and increasing geriatric population are expected to facilitate the expansion of the global market for peptic ulcer drugs over the forecast period.

Important players profiled in the Global Peptic Ulcer Drugs Market include:

• Daewoong Pharmaceutical Co., Ltd.
• Takeda Pharmaceutical Co., Ltd.
• Pfizer Inc.
• Abbott Laboratories
• AstraZeneca plc.
• RedHill Biopharma
• Cadila Healthcare Ltd.
• Novitium Pharma LLC
• Boehringer Ingelheim GmbH
• Eisai Co. Ltd.
• Yuhan Corporation
• GlaxoSmithKline plc.

Available Sample Report in PDF Version along with Graphs and Figures@ https://www.quincemarketinsights.com/request-sample-59137?utm_source=SK&utm_medium=Openpr&utm_campaign=SK

Growth Drivers that Support the Global Peptic Ulcer Drugs Market:
• The demand for peptic ulcer drugs is segmented into Gastric Ulcer, Gastritis, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD) based on the Disease Indication. During the forecast period, the duodenal ulcer segment is anticipated to lead the industry. Some of the factors attributable to its dominance during the forecast period are the increasing prevalence of duodenal ulcers, along with the increasing awareness of therapeutic start-ups for healthcare. For example, ANI Pharmaceuticals announced the launch of generic ranitidine capsules for the treatment of duodenal ulcers in July 2019, in collaboration with Appco Pharma.

• The industry is segmented into hospital pharmacies, specialty pharmacies, and online pharmacies in terms of distribution channels. During the forecast period, the hospital pharmacy segment is projected to have a dominant market share. The main factor contributing to its dominance is the rise in peptic ulcer diagnosed patient visits to hospitals to receive successful treatment. In addition, the ease of availability of peptic ulcer drugs in retail pharmacies is also driving the segment growth.

• It is estimated that North America will dominate the global market for peptic ulcers, accounting for the largest share during the forecast period. The rise in understanding of the treatment of peptic ulcers, the use of anti-inflammatory drugs, and the increase in the prevalence of stomach cancer in the region has propelled the market growth in North America. In addition, the key factors that drive the growth of the market in the region are unhealthy lifestyles, high spending on health care, and sophisticated health care infrastructure.

• Owing to an increase in the geriatric population, Europe is projected to account for a large share of the global market.

• During the forecast period, the Asia Pacific market is projected to develop at a faster growth rate. Because of the large population, increase in health consciousness and high prevalence of lifestyle-related diseases, stomach infections caused by H. Pylori, and cancer, it is the most lucrative market in the region. ⠀

Companies Seek to Expand their Global Foot-Print

• May 2020- Famotidine is under review at Northwell Health in New York City as a possible remedy for coronavirus, a common treatment for stomach ulcers.

• May 2020-FDA approval for the three-drug combination of omeprazole, amoxicillin, and rifabutin in one tablet, RHB-105, which effectively eradicates Helicobacter pylori infection in adults, was obtained by researchers from the Michael E. De-Bakey Veterans Affairs Medical Center.

Get ToC for the overview of the premium report @ https://www.quincemarketinsights.com/request-toc-59137?utm_source=SK&utm_medium=Openpr&utm_campaign=SK

Market Segment

By Product Type:
• Proton Pump Inhibitors
• Potassium-Competitive Acid Blocker (P-CAB)
• Antacids
• H2- Antagonists
• Antibiotics
• Ulcer Protective

By Disease Indication:
• Gastritis
• Gastric Ulcer
• Duodenal Ulcer
• Gastroesophageal Reflux Disease (GERD)

By Distribution Channel:
• Hospital Pharmacies
• Private Clinics
• Drug Stores
• Retail Pharmacies
• E-Commerce

By Region:
North America
• North America, by Country
• The U.S.
• Canada
• Mexico
• North America, by Product Type
• North America, by Disease Indication
• North America, by Distribution Channel

Europe
• Europe, by Country
• Germany
• The U.K.
• France
• Italy
• Spain
• Russia
• The Rest of Europe
• Europe, by Product Type
• Europe, by Disease Indication
• Europe, by Distribution Channel

Asia-Pacific
• Asia-Pacific, by Country
• China
• India
• Japan
• South Korea
• Australia
• The Rest of Asia-Pacific
• Asia-Pacific, by Product Type
• Asia-Pacific, by Disease Indication
• Asia-Pacific, by Distribution Channel

Middle East and Africa
• Middle East and Africa, by Country
• The UAE
• Saudi Arabia
• Qatar
• South Africa
• The Rest of Middle East and Africa
• Middle East and Africa, by Product Type
• Middle East and Africa, by Disease Indication
• Middle East and Africa, by Distribution Channel

South America
• South America, by Country
• Brazil
• Argentina
• The Rest of South America
• South America, by Product Type
• South America, by Disease Indication
• South America, by Distribution Channel

FAQs Answered in the Report
• In the peptic ulcer drugs industry, what are the most important regional markets?
• What is the market segmentation based on type?
• What is the market segmentation dependent on end-user?
• What are the different phases of the peptic ulcer drugs market’s value chain?
• What are the major drivers and threats in the peptic ulcer drugs market?
• Who are the main players in the peptic ulcer drugs market?
• What level of rivalry does the peptic ulcer drugs market have?
• What are the profit margins in the peptic ulcer drugs market?

Contact:
Quince Market Insights
Office No- A109
Pune, Maharashtra 411028
Phone: APAC +91 706 672 4848 / US +1 208 405 2835 / UK +44 121 364 6144
Email: sales@quincemarketinsights.com
Web: www.quincemarketinsights.com

ABOUT US:
QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the world's most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

This release was published on openPR.